AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth. Click here to read an analysis of ABCL ...

Democratizing Artificial Intelligence in Pre-Clinical Drug Discovery While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration ...

One of the first and most promising uses scientists envision for the rapidly evolving technology of quantum computing is a new approach to drug development. A quantum computer could, in theory ...

Harnessing state-of-the-art AI and automation technologies, Insilico has significantly improved the efficiency of preclinical drug development.

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.

A combination of two drugs- one for smoking cessation and another for depression- appear to work synergistically to treat alcohol use disorder. | Drug Discovery And Development ...

STAT’s Obesity Drug Tracker update looks at how China, a country with a low percentage of overweight people, became a hotbed of weight loss drug trials.

Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and ...

All of the basic research and early development behind a biotherapeutic, as well as the preclinical and clinical testing, go for naught without a successful final drug formulation. To benefit ...

Kazia on Wednesday announced positive preclinical data for its paxalisib drug in triple-negative breast cancer. The company's stock is soaring over 77% on exceptionally high and unusual trading ...